Company Filing History:
Years Active: 2017
Title: The Innovative Mind of Iris Delrue: Advancements in Virology
Introduction
Iris Delrue, an inventive scientist based in De Pinte, Belgium, has made significant contributions to the field of virology. With a focus on understanding viral inactivation procedures, Delrue has patented a method that stands out in the rapidly evolving landscape of antiviral research. Her work not only aims to better understand the implications of viral inactivation but also seeks to enhance vaccine development.
Latest Patents
Delrue’s most notable patent, titled "Determination of Antigenicity of an Inactivated Virus," delves into methods for evaluating the antigenicity of viruses that undergo inactivation. This patent primarily addresses viruses from the families Arteriviridae and Coronaviridae, with a particular focus on the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). The significance of this invention lies in its ability to assess how different inactivation procedures affect the antigenicity of the virus, paving the way for more effective vaccine formulations. Furthermore, the patent outlines methods for screening antiviral compounds and using the inactivated viruses to produce immunogenic vaccines.
Career Highlights
As an accomplished inventor, Iris Delrue is associated with Universiteit Gent, where her research has been influential in the field of virology. Her dedication to enhancing our understanding of viral diseases is reflected in her innovative approaches to vaccine development and antiviral strategies.
Collaborations
Iris is known for her collaborative spirit, working alongside esteemed colleagues such as Peter Delputte and Hans Nauwynck. Together, they contribute to groundbreaking research that strives to combat viral infections and improve public health outcomes.
Conclusion
Iris Delrue is a remarkable inventor whose work is instrumental in the fight against viral diseases. Her patented methods for assessing the antigenicity of inactivated viruses serve as a foundation for future innovations in vaccine development. Delrue’s contributions highlight the importance of research and collaboration in the ever-growing field of virology, ensuring advancements that could benefit both animal and human health.